Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. | Nat Commun | 2023 | 37739939 | PubTator, text mining | PubMed |
| The effects of statins on the function and differentiation of blood cells. | Arch Med Sci | 2023 | 37732056 | PubTator, text mining | PubMed |
| Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence. | Genome Med | 2023 | 37723590 | PubTator, text mining | PubMed |
| Genome-wide identification, phylogenetic relationships and expression patterns of the NOD-like receptor (NLR) gene family in flounder (Paralichthys olivaceus). | Fish Shellfish Immunol | 2023 | 37722442 | PubTator, text mining | PubMed |
| Causal ALS genes impact the MHC class II antigen presentation pathway. | Proc Natl Acad Sci U S A | 2023 | 37722062 | PubTator, text mining | PubMed |
| Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors. | Mol Pharm | 2023 | 37721387 | PubTator, text mining | PubMed |
| Exploring the potential relationship between frozen shoulder and Dupuytren's disease through bioinformatics analysis and machine learning. | Front Immunol | 2023 | 37720213 | PubTator, text mining | PubMed |
| Mapping the splicing landscape of the human immune system. | Front Immunol | 2023 | 37711610 | PubTator, text mining | PubMed |
| In vivo CRISPR screen identifies LTN1 as a novel tumor suppressor ubiquitinating insulin-like growth factor 2 mRNA-binding protein 1 in hepatocellular carcinoma. | Hepatol Commun | 2023 | 37708447 | PubTator, text mining | PubMed |
| Differences in mutational signature of diffuse large B-cell lymphomas according to the primary organ. | Cancer Med | 2023 | 37706649 | PubTator, text mining | PubMed |
| Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells. | J Exp Med | 2023 | 37695525 | PubTator, text mining | PubMed |
| Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways. | Cells | 2023 | 37681924 | PubTator, text mining | PubMed |
| Integrated signaling and transcriptome analysis reveals Src family kinase individualities and novel pathways controlled by their constitutive activity. | Front Immunol | 2023 | 37680627 | PubTator, text mining | PubMed |
| Myeloid-specific blockade of notch signaling alleviates dopaminergic neurodegeneration in Parkinson's disease by dominantly regulating resident microglia activation through NF-κB signaling. | Front Immunol | 2023 | 37680624 | PubTator, text mining | PubMed |
| Unveiling the immunomodulatory shift: Epithelial-mesenchymal transition Alters immune mechanisms of amniotic epithelial cells. | iScience | 2023 | 37680464 | PubTator, text mining | PubMed |
| The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope? | Mol Ther Oncolytics | 2023 | 37680255 | PubTator, text mining | PubMed |
| Diagnosis of mixed infection and a primary immunodeficiency disease using next-generation sequencing: a case report. | Front Cell Infect Microbiol | 2023 | 37674579 | PubTator, text mining | PubMed |
| Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement. | Front Immunol | 2023 | 37671152 | PubTator, text mining | PubMed |
| A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma. | Front Oncol | 2023 | 37664028 | PubTator, text mining | PubMed |
| Role of toll-like receptors and nod-like receptors in acute lung infection. | Front Immunol | 2023 | 37662905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=16